Performant Survey Spotlights Top Healthcare Technology Initiatives | PHLT Stock News

Author's Avatar
Apr 17, 2025
  • 61.5% of healthcare leaders prioritize improving patient outcomes, per Performant Healthcare's (PHLT, Financial) HIMSS25 survey.
  • 77% believe AI and machine learning will significantly impact healthcare in the next five years.
  • Performant identifies over $1.3 billion in savings for the Medicare trust fund over the past three years.

Performant Healthcare, Inc. (PHLT) recently revealed key insights from a survey conducted at HIMSS25 involving 150 healthcare technology leaders. The survey highlights that 61.5% of respondents prioritize improving patient outcomes, while 77% anticipate AI and machine learning will have the greatest impact in the healthcare sector over the next five years.

The findings emerge as the healthcare system grapples with inefficiencies. The U.S. Government Accountability Office reported $162 billion in improper payments across 68 programs in FY 2024, with over half occurring in healthcare. Performant has played a critical role, uncovering more than $1.3 billion in savings for the Medicare trust fund in the last three years through its technology-enabled payment integrity services.

When selecting healthcare technology vendors, key factors for organizations include product reliability, customer support, and adherence to industry regulations. Performant focuses on leveraging AI and machine learning to optimize payment processes, reduce errors, and improve efficiency in both government and commercial healthcare markets.

Simeon Kohl, CEO of Performant, stressed the importance of addressing financial waste, stating, "While healthcare leaders at HIMSS focus on innovation and efficiency, the reality is that fraud, waste, and abuse have caused hundreds of billions of dollars of waste that could otherwise support patient care, health equity, and long-term system resilience."

Performant continues to support healthcare payers in identifying, preventing, and recovering wasteful payments, using advanced technology, analytics, and proprietary data assets. As the industry advances, the company remains committed to innovation and helping clients tackle financial inefficiencies plaguing the U.S. healthcare system.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.